Authors
Joanna Rhodes, MD, MSCE, is the director of the lymphoma program at the Rutgers Cancer Institute and assistant head of lymphoma at Robert Wood Johnson.
Christopher Shade, PhD, founder and CEO, Quicksilver Scientific.
Advertisement
Advertisement
Trending on AJMC
1
FDA Clears First Alzheimer Blood Test for Adults as Young as 40
2
MFN Drug Agreements Could Raise Prices Worldwide
3
Dosing, Tolerability, and Formulary Impact: Aripiprazole and Quetiapine XR in MDD
4
Newer Agents, New Advantages: Brexpiprazole, Cariprazine, and Lumateperone in MDD
5
